Premier Biomedical Inc (BIEI)

[animaljive]

true, but most of those companies aren't looking at $1B-$5B of expenditures over the next decade to get a cancer drug to market and aren't trying to patent a cancer treatment. It throws a wrench in whole thing. If the pain patch company was its own publicly traded company, I would be putting money into it long-term just as a gamble based on their perceived effectiveness of the product. They have manufactured some test patches, but they don't have manufacturing agreements yet because they don't know the demand of the product, so no one has any idea of potential net profit and how that could potentially offset the tremendous costs coming their way. It's all just guesses based off the CEO's comments or brief sentences...who is a smidgen biased:)